Search

Meyers, R. M., J. G. Bryan, J. M. McFarland, B. A. Weir, A. E. Sizemore, H. Xu, N. V. Dharia, et al. 2017. “Computational Correction of Copy Number Effect Improves Specificity of CRISPR-Cas9 Essentiality Screens in Cancer Cells”. Nat Genet 49: 1779-84.

Moffett, H. F., A. N. R. Cartwright, H. J. Kim, J. Godec, J. Pyrdol, T. Aijo, G. J. Martinez, et al. 2017. “Erratum: The MicroRNA MiR-31 Inhibits CD8(+) T Cell Function in Chronic Viral Infection”. Nat Immunol 18: 1173.

Febbo, P. G., M. Lowenberg, A. R. Thorner, M. Brown, M. Loda, and T. R. Golub. 2005. “Androgen Mediated Regulation and Functional Implications of Fkbp51 Expression in Prostate Cancer”. J Urol 173: 1772-7.

Frohling, S., C. Scholl, R. L. Levine, M. Loriaux, T. J. Boggon, O. A. Bernard, R. Berger, et al. 2007. “Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles”. Cancer Cell 12: 501-13.

Garraway, L. A., H. R. Widlund, M. A. Rubin, G. Getz, A. J. Berger, S. Ramaswamy, R. Beroukhim, et al. 2005. “Integrative Genomic Analyses Identify MITF As a Lineage Survival Oncogene Amplified in Malignant Melanoma”. Nature 436: 117-22.

Golub, T. R. 2001. “Genome-Wide Views of Cancer”. N Engl J Med 344: 601-2.

Golub, T. R. 2003. “Mining the Genome for Combination Therapies”. Nat Med 9: 510-1.

Golub, T. R. 2007. “Genomics: Global Views of Leukaemia”. Nature 446: 739-40.

Golub, T. R., G. F. Barker, K. Stegmaier, and D. G. Gilliland. 1996. “Involvement of the TEL Gene in Hematologic Malignancy by Diverse Molecular Genetic Mechanisms”. Curr Top Microbiol Immunol 211: 279-88.

Halmos, B., D. S. Basseres, S. Monti, F. D’Alo, T. Dayaram, K. Ferenczi, B. J. Wouters, C. S. Huettner, T. R. Golub, and D. G. Tenen. 2004. “A Transcriptional Profiling Study of CCAAT/Enhancer Binding Protein Targets Identifies Hepatocyte Nuclear Factor 3 Beta As a Novel Tumor Suppressor in Lung Cancer”. Cancer Res 64: 4137-47.